Reduction in prescription medication costs after laparoscopic gastric bypass

American Surgeon

Volumn 72, Issue 10, 2006, Pages 853-856

  Nguyen, Ninh T ^a   Varela, J Esteban ^a   Sabio, Allen ^a   Naim, Joseph ^a   Stamos, Michael ^a   Wilson, Samuel E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; GASTROINTESTINAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; COMORBIDITY; COST CONTROL; DIABETES MELLITUS; DRUG COST; DRUG USE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRESCRIPTION; STOMACH BYPASS; TREATMENT OUTCOME; WEIGHT REDUCTION; ECONOMICS; FOLLOW UP; LAPAROSCOPY; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; ROUX Y ANASTOMOSIS;

ADOLESCENT; ADULT; ANASTOMOSIS, ROUX-EN-Y; BODY MASS INDEX; COST SAVINGS; DIABETES COMPLICATIONS; DRUG COSTS; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; GASTROESOPHAGEAL REFLUX; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 33750702520     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Pender JR, Pories WJ. Epidemiology of obesity in the United States. Gastroenterol Clin North Am 2005;34:1-7.
2. Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000;232:515-29.
3. Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux- en-Y 500 patients: technique and results, with 3-60 month follow-up. Obes Surg 2000;10:233-9.
4. Heffer S, Smith S, Won G, et al. Health spending projections for 2001-2011: the latest outlook. Health Aff 2002;21:207-18.
5. Gould JC, Garren MJ, Starling JR. Laparoscopic gastric bypass results in decreased prescription medication costs within 6 months. J Gastrointest Surg 2004;8:983-7.
6. Snow LL, Weinstein LS, Hannon JK, et al. The effect of Roux-en-Y gastric bypass on prescription drug costs. Obes Surg 2004;14:1031-5.
7. Potteiger CE, Paragi PR, Inverso NA, et al. Bariatric surgery: shedding the monetary weight of prescription costs in the managed care arena. Obes Surg 2004;14:725-30.
8. Monk JS Jr, Dia Nagib N, Stehr W. Pharmaceutical savings after gastric bypass surgery. Obes Surg 2004;14:13-5.